Curis, Inc. ( CRIS ) announced that it has re initiated dosing in the single agent clinical trial on pipeline …read more
By using this site, you agree to the storage of cookies on your device for enhanced navigation, site analysis, and GATS's marketing. Data sharing with social media platforms might occur based on the privacy choices you make on those platforms. For specifics, see our Privacy Policy.OkayPrivacy policy